
Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 77% rating based on their Quantitative Momentum Investor model, which is based on the strategy of Wesley Gray. The model favors HIMS due to its strong and consistent intermediate-term relative performance, though return consistency and seasonality are neutral factors. The rating suggests that the strategy has some interest in the stock.
HIMS & HERS HEALTH INC (HIMS), a large-cap growth stock in the Biotechnology & Drugs industry, has received a 77% rating from Validea's Quantitative Momentum Investor model, based on Wesley Gray's published strategy. This model identifies stocks exhibiting strong and consistent intermediate-term relative performance. While a score of 80% or above typically indicates some interest from the strategy, HIMS's 77% rating, supported by a 'PASS' on 'DEFINE THE UNIVERSE' and 'TWELVE MINUS ONE MOMENTUM' criteria, suggests nascent interest. However, the model assigned 'NEUTRAL' ratings for 'RETURN CONSISTENCY' and 'SEASONALITY', indicating these factors are neither significantly positive nor negative according to the strategy's specific tests. The overall sentiment for HIMS is positive (0.7), aligning with the quantitative model's findings of favorable momentum characteristics, despite not yet reaching the 'strong interest' threshold of 90%.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment